211 related articles for article (PubMed ID: 1587406)
21. Colorectal dysplasia and carcinoma in patients with ulcerative colitis and primary sclerosing cholangitis.
Leidenius MH; Färkkilä MA; Kärkkäinen P; Taskinen EI; Kellokumpu IH; Höckerstedt KA
Scand J Gastroenterol; 1997 Jul; 32(7):706-11. PubMed ID: 9246712
[TBL] [Abstract][Full Text] [Related]
22. Endoscopic screening for dysplasia and mucosal aneuploidy in adolescents and young adults with childhood onset colitis.
Markowitz J; McKinley M; Kahn E; Stiel L; Rosa J; Grancher K; Daum F
Am J Gastroenterol; 1997 Nov; 92(11):2001-6. PubMed ID: 9362180
[TBL] [Abstract][Full Text] [Related]
23. Differences in colonic disease activity in patients with ulcerative colitis with and without primary sclerosing cholangitis: a case control study.
Lundqvist K; Broomé U
Dis Colon Rectum; 1997 Apr; 40(4):451-6. PubMed ID: 9106695
[TBL] [Abstract][Full Text] [Related]
24. Colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
Gurbuz AK; Giardiello FM; Bayless TM
Dis Colon Rectum; 1995 Jan; 38(1):37-41. PubMed ID: 7813342
[TBL] [Abstract][Full Text] [Related]
25. Tissue factor in ulcerative colitis, with and without concomitant primary sclerosing cholangitis.
Vessby J; Lampinen M; Åberg M; Rorsman F; Siegbahn A; Wanders A; Carlson M
Ups J Med Sci; 2019 Nov; 124(4):238-245. PubMed ID: 31774347
[No Abstract] [Full Text] [Related]
26. Epithelial markers of colorectal carcinogenesis in ulcerative colitis and primary sclerosing cholangitis.
Wohl P; Hucl T; Drastich P; Kamenar D; Spicak J; Honsova E; Sticova E; Lodererova A; Matous J; Hill M; Wohl P; Kucera M
World J Gastroenterol; 2013; 19(14):2234-41. PubMed ID: 23599650
[TBL] [Abstract][Full Text] [Related]
27. Primary sclerosing cholangitis and ulcerative colitis: potential cofactors in the dysplasia sequence.
Hanauer S
Gastroenterology; 1992 Jun; 102(6):2161-2. PubMed ID: 1587440
[No Abstract] [Full Text] [Related]
28. Duration and severity of primary sclerosing cholangitis is not associated with risk of neoplastic changes in the colon in patients with ulcerative colitis.
Navaneethan U; Kochhar G; Venkatesh PG; Lewis B; Lashner BA; Remzi FH; Shen B; Kiran RP
Gastrointest Endosc; 2012 May; 75(5):1045-1054.e1. PubMed ID: 22405258
[TBL] [Abstract][Full Text] [Related]
29. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis.
Soetikno RM; Lin OS; Heidenreich PA; Young HS; Blackstone MO
Gastrointest Endosc; 2002 Jul; 56(1):48-54. PubMed ID: 12085034
[TBL] [Abstract][Full Text] [Related]
30. Downregulated eosinophil activity in ulcerative colitis with concomitant primary sclerosing cholangitis.
Lampinen M; Fredricsson A; Vessby J; Martinez JF; Wanders A; Rorsman F; Carlson M
J Leukoc Biol; 2018 Jul; 104(1):173-183. PubMed ID: 29603385
[TBL] [Abstract][Full Text] [Related]
31. Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis?
Marelli L; Xirouchakis E; Kalambokis G; Cholongitas E; Hamilton MI; Burroughs AK
Gut; 2011 Sep; 60(9):1224-8. PubMed ID: 21402617
[TBL] [Abstract][Full Text] [Related]
32. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis of 16 observational studies.
Zheng HH; Jiang XL
Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):383-90. PubMed ID: 26938805
[TBL] [Abstract][Full Text] [Related]
33. Temporal trends in colon neoplasms in patients with primary sclerosing cholangitis and ulcerative colitis.
Navaneethan U; Venkatesh PG; Lashner BA; Remzi FH; Shen B; Kiran RP
J Crohns Colitis; 2012 Sep; 6(8):845-51. PubMed ID: 22398080
[TBL] [Abstract][Full Text] [Related]
34. Clinical characteristics of ulcerative colitis associated with primary sclerosing cholangitis in Korea.
Ye BD; Yang SK; Boo SJ; Cho YK; Yang DH; Yoon SM; Kim KJ; Byeon JS; Myung SJ; Yu CS; Yun SC; Kim JH
Inflamm Bowel Dis; 2011 Sep; 17(9):1901-6. PubMed ID: 21830268
[TBL] [Abstract][Full Text] [Related]
35. Risk for colorectal neoplasia in patients with colonic Crohn's disease and concomitant primary sclerosing cholangitis.
Braden B; Halliday J; Aryasingha S; Sharifi Y; Checchin D; Warren BF; Kitiyakara T; Travis SP; Chapman RW
Clin Gastroenterol Hepatol; 2012 Mar; 10(3):303-8. PubMed ID: 22037429
[TBL] [Abstract][Full Text] [Related]
36. The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis.
Marchesa P; Lashner BA; Lavery IC; Milsom J; Hull TL; Strong SA; Church JM; Navarro G; Fazio VW
Am J Gastroenterol; 1997 Aug; 92(8):1285-8. PubMed ID: 9260790
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitis.
Culver EL; Bungay HK; Betts M; Forde C; Buchel O; Manganis C; Warren BF; Cummings FR; Keshav S; Travis SPL; Chapman RW
Liver Int; 2020 Nov; 40(11):2744-2757. PubMed ID: 32841490
[TBL] [Abstract][Full Text] [Related]
38. Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction?
Jayaram H; Satsangi J; Chapman RW
Gut; 2001 Mar; 48(3):430-4. PubMed ID: 11171838
[No Abstract] [Full Text] [Related]
39. Unique Phenotypic Characteristics and Clinical Course in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Multicenter US Experience.
Wang MH; Mousa OY; Friton JJ; Raffals LE; Leighton JA; Pasha SF; Picco MF; Cushing KC; Monroe K; Nix BD; Newberry RD; Faubion WA
Inflamm Bowel Dis; 2020 Apr; 26(5):774-779. PubMed ID: 31626701
[TBL] [Abstract][Full Text] [Related]
40. DNA aneuploidy and histologic dysplasia in long-standing ulcerative colitis. A 10-year follow-up study.
Befrits R; Hammarberg C; Rubio C; Jaramillo E; Tribukait B
Dis Colon Rectum; 1994 Apr; 37(4):313-9; discussion 319-20. PubMed ID: 8168409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
